Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-005417

CEO and Chairman sold 33,360 shares at an average $30.71 ($1,024,586)

  • CEO and Chairman acquired 33,360 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2020-01-27 Exercise or conversion : show line 1 in the form +11,120 $0.33 $3,670 1,889,300 D
2020-01-27 Sale : show line 2 in the form −11,120 $30.01 $333,711 1,878,180 D
2020-01-28 Exercise or conversion : show line 3 in the form +11,120 $0.33 $3,670 1,889,300 D
2020-01-28 Sale : show line 4 in the form −10,320 $31.08 $320,746 1,878,980 D
2020-01-28 Sale : show line 5 in the form −800 $31.90 $25,520 1,878,180 D
2020-01-29 Exercise or conversion : show line 6 in the form +11,120 $0.33 $3,670 1,889,300 D
2020-01-29 Sale : show line 7 in the form −11,120 $30.99 $344,609 1,878,180 D
Open-market sales · 33,360 sh · avg $30.71 · $1,024,586

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-01-27 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −11,120 768,800 D
2020-01-28 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −11,120 757,600 D
2020-01-29 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −11,120 746,400 D
Loading xslF345X03/doc4.xml…